Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein

被引:122
作者
Daub, H
Blencke, S
Habenberger, P
Kurtenbach, A
Dennenmoser, J
Wissing, J
Ullrich, A
Cotten, M
机构
[1] Axxima Pharmaceut AG, D-82152 Martinsried, Germany
[2] Max Planck Inst Biochem, Dept Biol Mol, D-82152 Martinsried, Germany
[3] Tech Univ Braunschweig, Dept Biochem, D-38124 Braunschweig, Germany
关键词
D O I
10.1128/JVI.76.16.8124-8137.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Phosphorylation of hepatitis B virus (HBV) core protein has recently been shown to be a prerequisite for pregenomic RNA encapsidation into viral capsids, but the host cell kinases mediating this essential step of the HBV replication cycle have not been identified. We detected two kinases of 95 and 115 kDa in HuH-7 total cell lysates which interacted specifically with the HBV core protein and phosphorylated its arginine-rich C-terminal domain. The 95-kDa kinase was purified and characterized as SR protein-specific kinase I (SRPK1) by mass spectrometry. Based on this finding, the 115-kDa kinase could be identified as the related kinase SRPK2 by immunoblot analysis. In vitro, both SRPKs phosphorylated HBV core protein on the same serine residues which are found to be phosphorylated in vivo. Moreover, the major cellular HBV core kinase activity detected in the total cell lysate showed biochemical properties identical to those of SRPK1 and SRPK2, as examined by measuring binding to a panel of chromatography media. We also clearly demonstrate that neither the cyclin-dependent kinases Cdc2 and Cdk2 nor protein kinase C, previously implicated in HBV core protein phosphorylation, can account for the HBV core protein kinase activity. We conclude that both SRPK1 and SRPK2 are most likely the cellular protein kinases mediating HBV core protein phosphorylation during viral infection and therefore represent important host cell targets for therapeutic intervention in HBV infection.
引用
收藏
页码:8124 / 8137
页数:14
相关论文
共 47 条
[1]   PROTEIN-KINASE ACTIVITY IN HEPATITIS-B VIRUS [J].
ALBIN, C ;
ROBINSON, WS .
JOURNAL OF VIROLOGY, 1980, 34 (01) :297-302
[2]  
AZZI L, 1994, J BIOL CHEM, V269, P13279
[3]   THE P-GENE PRODUCT OF HEPATITIS-B VIRUS IS REQUIRED AS A STRUCTURAL COMPONENT FOR GENOMIC RNA ENCAPSIDATION [J].
BARTENSCHLAGER, R ;
JUNKERNIEPMANN, M ;
SCHALLER, H .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5324-5332
[4]  
BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
[5]  
2-J
[6]   HEPATITIS-B VIRUS HBX PROTEIN DEREGULATES CELL-CYCLE CHECKPOINT CONTROLS [J].
BENN, J ;
SCHNEIDER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11215-11219
[7]   Identification of in-gel digested proteins by complementary peptide mass fingerprinting and tandem mass spectrometry data obtained on an electrospray ionization quadrupole time-of-flight mass spectrometer [J].
Borchers, C ;
Peter, JF ;
Hall, MC ;
Kunkel, TA ;
Tomer, KB .
ANALYTICAL CHEMISTRY, 2000, 72 (06) :1163-1168
[8]   ANISOMYCIN-ACTIVATED PROTEIN KINASE-P45 AND KINASE-P55 BUT NOT MITOGEN-ACTIVATED PROTEIN KINASE-ERK-1 AND KINASE-ERK-2 ARE IMPLICATED IN THE INDUCTION OF C-FOS AND C-JUN [J].
CANO, E ;
HAZZALIN, CA ;
MAHADEVAN, LC .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (11) :7352-7362
[9]   Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli [J].
Chartier, C ;
Degryse, E ;
Gantzer, M ;
Dieterle, A ;
Pavirani, A ;
Mehtali, M .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4805-4810
[10]   SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors [J].
Colwill, K ;
Feng, LL ;
Yeakley, JM ;
Gish, GD ;
Caceres, JF ;
Pawson, T ;
Fu, XD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24569-24575